Intracellular rod-like crystals in chronic lymphocyte leukemia Yiling HuangLixia Zhang Images in Hematology 14 July 2020 Pages: 267 - 267
JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN) Kazuya ShimodaNaoto TakahashiMasahiro Kizaki Guideline 11 August 2020 Pages: 268 - 291
Current insights into the treatments of severe aplastic anemia in China Lei YeFengkui ZhangSeiji Kojima Review Article 03 August 2020 Pages: 292 - 299
A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo Masumichi SaitoHiroo HasegawaKatsunori Yanagihara Rapid Communication 29 July 2020 Pages: 300 - 306
Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan Toyomi KamesakiJun-ichi NishimuraYuzuru Kanakura Original Article 30 June 2020 Pages: 307 - 315
Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells Aya FujishiroMasaki IwasaYasuo Miura Original Article 22 June 2020 Pages: 316 - 330
Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C Takahiro KaidoMasahiro YodaNobuo Okumura Original Article 19 June 2020 Pages: 331 - 340
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy Yukiko KawaguchiBungo SaitoTsuyoshi Nakamaki Original Article 10 June 2020 Pages: 341 - 348
Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy Hideho HenzanKen Takasefor the Fukuoka Blood & Marrow Transplantation Group (FBMTG) Original Article 10 June 2020 Pages: 349 - 360
Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis Alexandre NoninoPaulo Vidal CampregherRinaldo Wellerson Pereira Original Article 13 June 2020 Pages: 361 - 368
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study Takashi IkedaShin-ichiro FujiwaraYoshinobu Kanda Original Article 11 June 2020 Pages: 369 - 376
Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera Ivan KrečakHrvoje HolikVelka Gverić-Krečak Original Article 08 June 2020 Pages: 377 - 384
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan Yu-Hung WangShan-Chi YuTai-Chung Huang Original Article 09 June 2020 Pages: 385 - 394
Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator Hisashi TakeiHirofumi FukudaSusumu S. Kobayashi Original Article 12 June 2020 Pages: 395 - 408
Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group Shun-ichi KimuraHiroyuki FujitaJapan Adult Leukemia Study Group (JALSG) Original Article 18 June 2020 Pages: 409 - 417
Ruxolitinib as first-line therapy in secondary hemophagocytic lymphohistiocytosis and HIV infection Sergio Gálvez AcostaMariana Javalera Rincón Case Report 13 April 2020 Pages: 418 - 421
Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy Kentaro MizuharaNobuharu FujiiYoshinobu Maeda Case Report 27 April 2020 Pages: 422 - 426
Toward further simplification of elotuzumab therapy by subcutaneous administration Yuji ShimuraTaku TsukamotoJunya Kuroda Letter to the Editor 13 July 2020 Pages: 427 - 428
J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors Sho OkamotoHiroshi UreshinoShinya Kimura Letter to the Editor 12 July 2020 Pages: 429 - 430
Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy Hideho HenzanKen Takasefor the Fukuoka Blood & Marrow Transplantation Group (FBMTG) Correction 08 July 2020 Pages: 431 - 432
